Latest AI and machine learning research in hemophilia for healthcare professionals.
Biologists frequently desire protein inhibitors for a variety of reasons, including use as researc...
The identification of an effective inhibitor is an important starting step in drug development. Unfo...
Predictive biomarkers of treatment response are lacking for metastatic clear cell renal cell carci...
Tumor mutational burden (TMB) is a significant predictive biomarker for selecting patients that may ...
PURPOSE: Evaluation of PD-L1 tumor proportion score (TPS) by pathologists has been very impactful bu...
BACKGROUND: Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a fatal adverse event of immu...
CLINICAL RATIONALE FOR STUDY: We have reported that intracerebral haemorrhage (ICH) of unknown cause...
Entamoeba histolytica is the parasite responsible for amoebiasis, which can result in amoebic coliti...
OBJECTIVES: Our objectives were to estimate the incidence of venous thromboembolism (VTE) after robo...
Dense connective tissue, including the ligament, tendon, fascia and cornea, is formed by regularly a...
Drug resistance is a major threat to the global health and a significant concern throughout the clin...
BACKGROUND/AIM: The aim of the study was to evaluate the risk of venous thromboembolism (VTE) after ...
Although natural products are rich sources for drug discovery, only a small percentage of natural pr...
Dermatomyositis is a common connective tissue disease. The occurrence and development of dermatomyos...
Atrial fibrillation (AF) is common in the elderly. The treatment of this condition is based on antic...
Rivastigmine is a non-competitive reversible inhibitor of acetylcholinesterase which is approved as ...
Allogeneic hematopoietic stem cell transplantation (AHSCT) is a major method of treatment for differ...
BACKGROUND: Cytokine-induced killer (CIK) cells and natural killer (NK) cells are employed by two di...
Present study is conducted to investigate the efficacy and safety of application of low-molecular-we...
BACKGROUND: The gut-selective nature of vedolizumab has raised questions regarding increased joint p...